精密科学（Exact Sciences Corp，股票代码：EXAS）今日盘前大跌14.94%，尽管公司刚刚发布了好于预期的季度财报。这一反常现象引发了市场的广泛关注。
根据公司发布的截至6月30日的季度财报，精密科学实现调整后每股亏损1美分，远好于分析师平均预期的19美分亏损，也优于去年同期的9美分亏损。公司营收同比增长16%，达到8.1109亿美元，同样超过分析师预期的7.7467亿美元。然而，这些看似积极的数据并未能提振投资者信心。
分析人士指出，尽管季度业绩超预期，但市场似乎更关注公司的长期发展前景。过去三个月内，分析师对公司的平均盈利预期下降了约24.6%，反映出市场对公司未来增长的担忧。此外，精密科学股价今年迄今累计下跌15.7%，这种持续的下行趋势可能加剧了投资者的担忧情绪。市场可能正在重新评估公司的估值水平，这或许是导致盘前股价大幅下跌的主要原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.